|Last Price||Today's Change||52-Week Range||Trading Volume|
|62.43||-0.25 (-0.40%)||56.27 - 89.00||547.6 thousand|
Market data as of 12:24PM 10/08/15. Quotes are delayed by at least 15 min.
Quest Diagnostics To Release Third Quarter 2015 Financial Results On October 22
10/05/2015 3:15 PM ET
Quest Diagnostics Introduces Dako's PD-L1 Companion Diagnostic for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression On or After Platinum-Containing Chemotherapy
10/02/2015 3:39 PM ET